SCHEMBL8780454

SCHEMBL8780454

C=CC([N]C(=O)O)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.43
CYP2D6 P10635 1/20 0.40
SRC P12931 1/20 0.40
LMNA P02545 4/20 0.39
MAPK1 P28482 1/20 0.39
CES2 O00748 2/20 0.38
CES1 P23141 2/20 0.38
AKT1 P31749 1/20 0.38
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HPGD P15428 1/20 0.36
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC10 Q969S8 1/20 0.35
HDAC11 Q96DB2 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3258485 0.77 KDM4E (0.40) CYP2C19CYP2D6SRCLMNAMAPK1
SCHEMBL3261585 0.76 CYP2C19 (0.36) CYP2C19CYP2D6SRCLMNATDP1
SCHEMBL10452869 0.73 CYP2C19 (0.36) CYP2C19CYP2D6SRCLMNAMAPK1
SCHEMBL11766335 0.73 CYP2D6 (0.37) CYP2C19CYP2D6SRCLMNAMAPK1
SCHEMBL1047388 0.72 CYP2C19 (0.35) CYP2C19CYP2D6SRCLMNAMAPK1
SCHEMBL8525246 0.71 ALDH1A1 (0.35) CYP2C19LMNATDP1L3MBTL1HPGD
Formic Acid SCHEMBL1162475 0.71 CYP2D6 (0.35) CYP2C19CYP2D6SRCLMNAMAPK1
SCHEMBL1162464 0.71 CYP2C19 (0.35) CYP2C19CYP2D6SRCLMNAMAPK1
SCHEMBL28429021 0.69 CYP2C19 (0.34) CYP2C19CYP2D6SRCLMNATDP1
Phosphonic Acid SCHEMBL1162520 0.69 CYP2C19 (0.34) CYP2C19CYP2D6SRCLMNATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0498722-B1 Bicyclic nitrogen compounds, their preparation, intermediates obtained, their use as pharmaceuticals and pharmaceutical compositions containing them ROUSSEL UCLAF (FR) 1997-07-30 EP disclosed